Nalls Sherbakoff Group’s Zimmer Biomet ZBH Stock Holding History

Nalls Sherbakoff Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$2.68K	Buy	30 +26	+650%	+$2.46K	﹤0.01%	396
2025 Q3	$394	Hold	4	–	–	﹤0.01%	413
2025 Q2	$365	Hold	4	–	–	﹤0.01%	415
2025 Q1	$453	Buy	+4	New	+$428	﹤0.01%	419
2023 Q4	$487	Hold	4	–	–	﹤0.01%	417
2023 Q3	$449	Hold	4	–	–	﹤0.01%	433
2023 Q2	$510	Hold	4	–	–	﹤0.01%	447
2023 Q1	$508	Buy	+4	New	+$502	﹤0.01%	484

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Nalls Sherbakoff Group's ZBH Position: Q4 2025 in Review

Nalls Sherbakoff Group increased its Zimmer Biomet (ZBH) stake by 650% in Q4 2025, buying an estimated $2.46K and bringing the position to 30 shares worth $2.68K. The position accounts for ﹤0.01% of the portfolio, ranked #396.

Nalls Sherbakoff Group first reported a position in ZBH in Q1 2023 and has held it in 8 quarters since. 946 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.

Nalls Sherbakoff Group held 30 shares of Zimmer Biomet worth $2.68K as of Q4 2025.
Nalls Sherbakoff Group bought 26 Zimmer Biomet shares in Q4 2025, an estimated $2.46K.
Zimmer Biomet made up ﹤0.01% of Nalls Sherbakoff Group's portfolio in Q4 2025, its #396 holding.
Nalls Sherbakoff Group first reported a position in Zimmer Biomet in Q1 2023 and has held it in 8 quarters since.
946 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.

Based on Nalls Sherbakoff Group's 13F filing for Q4 2025, filed 12 Mar 2026.